Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
25 July 2001Website:
http://www.zimmerbiomet.comNext earnings report:
07 February 2025Last dividends:
30 September 2024Next dividends:
N/APrice
after hours | Wed, 20 Nov 2024 23:17:47 GMTAnalysts recommendations
Institutional Ownership
Included in screeners
ZBH Latest News
Zimmer Biomet has received CE Mark Certification for its Persona Revision Knee System, which was successfully launched in the United States and other regions.
On November 18, 2024, Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a leading company in medical technology, announced that it has obtained the CE Mark for its Persona® Revision Knee System. This certification allows the product to be sold in European markets.
Zimmer Biomet anticipates that the ROSA and Persona Cementless Knee will quickly boost its presence in the robotics and cementless market to between 50% and 60%.
Zimmer Biomet shows impressive results in various areas and locations during the third quarter of 2024.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) will hold its Q3 2024 Earnings Conference Call on October 30, 2024, at 8:30 AM ET. Key company participants include David DeMartino, Ivan Tornos, and Suketu Upadhyay. Various analysts from major financial institutions will also be joining the call.
While the revenue and earnings per share (EPS) for Zimmer (ZBH) provide insight into its performance for the quarter ending September 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.
Zimmer Biomet, a company that makes hip implants, reduced its yearly profit expectations on Wednesday. This change came after problems with a software system that was handling parts of the company's operations last month.
On Wednesday, Zimmer Biomet Holdings, Inc. (ZBH) announced that its adjusted earnings per share (EPS) for the third quarter was $1.74, an increase from $1.65 the previous year, matching analysts' expectations.
Zimmer Biomet's results for the third quarter are expected to show strong performance in its three main business areas: Hips, Knees, and S.ET.
WARSAW, Ind., Oct. 9, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) has announced that it will hold a conference call to discuss its third quarter earnings. The call will be available via webcast on Wednesday, October 30, 2024, at 8:30 a.m.
What type of business is Zimmer Biomet Holdings?
Zimmer Biomet Holdings is a well-known global manufacturer of innovative medical equipment for patients suffering from bone, joint, and soft tissue disorders or injuries. The company develops, manufactures, and sells orthopedic reconstructive devices; products for sports medicine, biologics, treatments for limb and spine injuries (plates, implants, prosthetics, etc.); products for craniofacial, thoracic, dental surgery, and other related surgical products. Zimmer Biomet Holdings was registered in 2001, with the predecessor's work history starting in 1927. The company's headquarters and main research center are located in Warsaw, Indiana.
What sector is Zimmer Biomet Holdings in?
Zimmer Biomet Holdings is in the Healthcare sector
What industry is Zimmer Biomet Holdings in?
Zimmer Biomet Holdings is in the Medical Devices industry
What country is Zimmer Biomet Holdings from?
Zimmer Biomet Holdings is headquartered in United States
When did Zimmer Biomet Holdings go public?
Zimmer Biomet Holdings initial public offering (IPO) was on 25 July 2001
What is Zimmer Biomet Holdings website?
https://www.zimmerbiomet.com
Is Zimmer Biomet Holdings in the S&P 500?
Yes, Zimmer Biomet Holdings is included in the S&P 500 index
Is Zimmer Biomet Holdings in the NASDAQ 100?
No, Zimmer Biomet Holdings is not included in the NASDAQ 100 index
Is Zimmer Biomet Holdings in the Dow Jones?
No, Zimmer Biomet Holdings is not included in the Dow Jones index
When was Zimmer Biomet Holdings the previous earnings report?
No data
When does Zimmer Biomet Holdings earnings report?
The next expected earnings date for Zimmer Biomet Holdings is 07 February 2025